Cargando…
LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome
A novel serine/threonine protein kinase, LmjF.22.0810, was recently described in Leishmania major. After generating an L. major cell line overexpressing LmjF.22.0810 (named LmJ3OE), the ability of this novel protein to modulate the Th2-type immune response was analyzed. Our results suggest that the...
Autores principales: | Vacas, Andrés, Fernández-Rubio, Celia, Larrea, Esther, Peña-Guerrero, José, Nguewa, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692454/ https://www.ncbi.nlm.nih.gov/pubmed/33114674 http://dx.doi.org/10.3390/biomedicines8110452 |
Ejemplares similares
-
The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major May Be Involved in the Resistance to Drugs such as Paromomycin
por: Vacas, Andrés, et al.
Publicado: (2019) -
Identification of the Leishmania major Proteins LmjF07.0430, LmjF07.0440, and LmjF27.2440 as Components of Fatty Acid Synthase II
por: Gurvitz, Aner
Publicado: (2009) -
The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells
por: Larrea, Esther, et al.
Publicado: (2022) -
Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis
por: Peña-Guerrero, José, et al.
Publicado: (2021) -
In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity
por: Algarabel, Miriam, et al.
Publicado: (2021)